MY137618A - Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading - Google Patents

Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading

Info

Publication number
MY137618A
MY137618A MYPI20013909A MYPI20013909A MY137618A MY 137618 A MY137618 A MY 137618A MY PI20013909 A MYPI20013909 A MY PI20013909A MY PI20013909 A MYPI20013909 A MY PI20013909A MY 137618 A MY137618 A MY 137618A
Authority
MY
Malaysia
Prior art keywords
drug
solution
solution composition
concentration
enhanced
Prior art date
Application number
MYPI20013909A
Inventor
Sandra M Sims
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of MY137618A publication Critical patent/MY137618A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

THERE IS PROVIDED A PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC OR PROPHYLACTIC ADMINISTRATION TO A SUBJECT HAVING AN INFECTIVE DISEASE OR CONDITION OR AT RISK THEREOF. THE COMPOSITION COMPRISES AN AQUEOUS CARRIER HAVING IN SOLUTION THEREIN (A) AN OXAZOLIDINONE ANTIMICROBIAL DRUG, FOR EXAMPLE LINEZOLID, IN A THERAPEUTICALLY OR PROPHYLACTICALLY EFFECTIVE DRUG CONCENTRATION THAT IS ABOVE THE PRATICAL LIMIT OF SOLUBILITY OF THE DRUG IN A SUBSTANTIALLY ISOTONIC AQUEOUS SOLUTION AT A PHYSIOLOGICALLY COMPATIBLE PH, AND (B) A PHARMACEUTICALLY ACCEPTABLE CYCLODEXTRIN COMPOUND IN A CONCENTRATION SUFFICIENT TO MAINTAIN THE DRUG IN SOLUTION AT SUCH A DRUG CONCENTRATION. THE COMPOSITION IS PARTICULARLY USEFUL FOR INTRAVENOUS DELIVERY OF THE DRUG.
MYPI20013909A 2000-08-22 2001-08-20 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading MY137618A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22684600P 2000-08-22 2000-08-22

Publications (1)

Publication Number Publication Date
MY137618A true MY137618A (en) 2009-02-27

Family

ID=32849339

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20013909A MY137618A (en) 2000-08-22 2001-08-20 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading

Country Status (3)

Country Link
CN (1) CN1713924A (en)
MY (1) MY137618A (en)
ZA (1) ZA200301281B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2776310A1 (en) * 2009-10-13 2011-04-21 Rib-X Pharmaceuticals, Inc. Pharmaceutical compositions of radezolid and theur use in treting, preventing, or reducing the risk of microbial infections
CN101766628B (en) * 2010-01-20 2012-07-04 广东宏盈科技有限公司 Ophthalmic bacterial-infection resisting medicine for external use
WO2012104874A2 (en) * 2011-02-02 2012-08-09 Mylan Laboratories Limited. Aqueous concentrated formulation of linezolid
WO2013024398A2 (en) * 2011-08-12 2013-02-21 Alembic Pharmaceuticals Limited An improved method for the quantitative determination of linezolid
CN102643251B (en) * 2012-04-17 2016-08-10 四川美大康佳乐药业有限公司 degradation impurity of linezolid and preparation method thereof
CN107648181B (en) * 2016-07-25 2021-05-04 广东赛法洛药业有限公司 Ritazodone phospholipid complex and preparation method and application thereof

Also Published As

Publication number Publication date
CN1713924A (en) 2005-12-28
ZA200301281B (en) 2004-02-17

Similar Documents

Publication Publication Date Title
WO2002043765A3 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
AU1079701A (en) Oral transmucosal drug dosage using solid solution
DK1320355T3 (en) System for administering a tobramycin formulation
EA200401216A1 (en) DOSED FORMS OF AZITROMYCIN WITH REDUCED SIDE EFFECTS
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
WO2004002447A3 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
UA88270C2 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes
CO5560580A2 (en) FORMULATIONS OF SUCRALOSE TO DISPENSE FLAVORABLE FLAVORS
EA200401009A1 (en) PRELIMINARY GELATINIZED STARCH IN COMPOSITION WITH CONTROLLED DELIVERY
CY1105464T1 (en) SOLUTION OF AN OXAZOLIDINONE ANTIBIOTIC DRUG
MY118371A (en) Tetrahydrolipstatin containing compositions
GEP20053473B (en) High Potency Dihydroergotamine Compositions
MXPA02011003A (en) Stable metal ion lipid powdered pharmaceutical compositions for drug delivery and methods of use.
KR20070067189A (en) Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
WO2001082897A3 (en) Liposome drug delivery
NZ503946A (en) Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments
RU2004133347A (en) DRUG FOR PREVENTION AND / OR TREATMENT OF CHRONIC REFUSAL
EA200200812A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LOW DOSE OF ENTEKAVIR, AND ITS APPLICATION
CO5170471A1 (en) MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
SI1383752T1 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
WO2001047913A3 (en) Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect
RU2009123536A (en) Stable parenteral formulations, including benzodiazepine-based PCB inhibitors
GB2368525A (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
MY137618A (en) Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading